This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brat, D. J. Articles by Hruban, R. H. Search for Related Content PubMed PubMed Citation Articles by Brat, D. J. Articles by Hruban, R. H.

American Journal of Pathology, Vol 150, 383-391, Copyright © 1997 by American Society for Investigative Pathology

REGULAR ARTICLES

The structural basis of molecular genetic deletions. An integration of classical cytogenetic and molecular analyses in pancreatic adenocarcinoma

DJ Brat, SA Hahn, CA Griffin, CJ Yeo, SE Kern and RH Hruban
Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.

Molecular genetic alterations are known to be important in human carcinoma, but the structural basis of these changes is largely unknown. To examine the basis of these changes, we compared the karyotypic chromosomal abnormalities of primary pancreatic adenocarcinomas with the molecular changes identified in these same cancers. In 14 cancers with abnormal karyotypes, 65% (123 of 188) of the chromosomal arms with molecular loss of heterozygosity (LOH) were associated with karyotypic structural anomalies. Karyotypic changes accounting for these molecular allelic losses included 83 chromosome losses, 18 partial deletions, nine isochromosomes, eight additions, and five translocations. Eight bomozygous deletions were also identified by molecular analyses. Of the three homozygous deletions identified at 9p21, the only karyotypic change was a single case in which one entire copy of chromosome 9 was deleted. Of the four homozygous deletions identified at 18q21.1, one showed a loss of both copies of chromosome 18, two showed a loss of one copy of chromosome 18, and the fourth had two structurally normal copies of chromosome 18. One homozygous deletion was identified at 13q12.3, and the karyotype revealed the loss of one entire copy of chromosome 13. The second copy of chromosome 13 in this carcinoma was structurally normal. These results indicate that chromosomal structural anomalies can account for two-thirds of the LOH in pancreatic adenocarcinomas and that most homozygous deletions are likely to be interstitial chromosomal deletions that are below the detection limit of conventional karyotypic analyses. Some of the molecular deletions detected as LOH on chromosomes with karyotypically normal structure can be explained by chromosomal loss with reduplication of the remaining chromosome.

This article has been cited by other articles:

				D. Furlan, B. Bernasconi, S. Uccella, R. Cerutti, I. Carnevali, and C. Capella Allelotypes and Fluorescence In situ Hybridization Profiles of Poorly Differentiated Endocrine Carcinomas of Different Sites Clin. Cancer Res., March 1, 2005; 11(5): 1765 - 1775. [Abstract] [Full Text] [PDF]

				B. TYCKO Genetic and Epigenetic Mosaicism in Cancer Precursor Tissues Ann. N.Y. Acad. Sci., March 1, 2003; 983(1): 43 - 54. [Abstract] [Full Text] [PDF]

				N. T. van Heek, A. K. Meeker, S. E. Kern, C. J. Yeo, K. D. Lillemoe, J. L. Cameron, G. J. A. Offerhaus, J. L. Hicks, R. E. Wilentz, M. G. Goggins, et al. Telomere Shortening Is Nearly Universal in Pancreatic Intraepithelial Neoplasia Am. J. Pathol., November 1, 2002; 161(5): 1541 - 1547. [Abstract] [Full Text] [PDF]

				M.-F. Rousseau-Merck, I. Versteege, I. Legrand, J. Couturier, A. Mairal, O. Delattre, and A. Aurias hSNF5/INI1 Inactivation Is Mainly Associated with Homozygous Deletions and Mitotic Recombinations in Rhabdoid Tumors Cancer Res., July 1, 1999; 59(13): 3152 - 3156. [Abstract] [Full Text] [PDF]